Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Revenues (Tables)

v3.19.1
Revenues (Tables)
 12 Months Ended
Dec. 31, 2018
Revenues [Abstract]  
Schedule of revenues

 

    2017     2018  
    NIS in
thousands		  
Revenues from the sales of goods     1,668       2,657  
Revenues from the rendering of services     -       682  
Revenues from licensing agreement (see Note 2N)     -       14,695  
      1,668       18,034  
Schedule of revenues by geographical area

 

 
    2017     2018  
    NIS in
thousands		  
United states and Canada     802       17,511  
Europe     866       523  
      1,668       18,034
Schedule of major customers

 

 
    2017     2018  
    NIS in
thousands		  
Customer A     688       15,375  
                 
Customer B     521       -  
                 
Customer C     295       -  
                 
Customer D     -       1,816
Schedule of contract liability relating to goods

 

    2018  
    NIS in
thousands		  
Balance as of January 1, 2018     -  
Contract liability recognized due to LB agreement     7,346  
Revenue recognized during the period     (37 )
Balance as of December 31, 2018(1)     7,309  
Contract liability presented in current liabilities     3,636  
Contract liability presented in non-current liabilities(2)     3,673  

 

(1) Represents the unfulfilled performance obligation related to First BioInk.
(2) As of December 31, 2018, non-current contract liabilities are estimated to be recognized in 2020.